

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.40596010 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.40596010 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.01403531 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.01403531 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.82690019 |
| 6 | tryptophan catabolic process (GO:0006569) | 6.32949714 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.32949714 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.32949714 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.13896241 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.01673542 |
| 11 | tryptophan metabolic process (GO:0006568) | 5.96349931 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.81421267 |
| 13 | urea cycle (GO:0000050) | 5.69332564 |
| 14 | urea metabolic process (GO:0019627) | 5.69332564 |
| 15 | intestinal cholesterol absorption (GO:0030299) | 5.59627722 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.56018278 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.52888883 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 5.42062393 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.35517122 |
| 20 | protein carboxylation (GO:0018214) | 5.33168694 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.33168694 |
| 22 | regulation of fibrinolysis (GO:0051917) | 5.31095248 |
| 23 | regulation of protein activation cascade (GO:2000257) | 5.29628715 |
| 24 | complement activation, alternative pathway (GO:0006957) | 5.26983044 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 5.24348441 |
| 26 | regulation of plasminogen activation (GO:0010755) | 5.22014428 |
| 27 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.16332217 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.07710371 |
| 29 | bile acid metabolic process (GO:0008206) | 5.02380539 |
| 30 | aromatic amino acid family metabolic process (GO:0009072) | 4.99151317 |
| 31 | regulation of complement activation (GO:0030449) | 4.95360205 |
| 32 | omega-hydroxylase P450 pathway (GO:0097267) | 4.93842653 |
| 33 | tyrosine metabolic process (GO:0006570) | 4.93030873 |
| 34 | reverse cholesterol transport (GO:0043691) | 4.91901705 |
| 35 | epoxygenase P450 pathway (GO:0019373) | 4.91815294 |
| 36 | cysteine metabolic process (GO:0006534) | 4.88537014 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.85736518 |
| 38 | serine family amino acid catabolic process (GO:0009071) | 4.84067931 |
| 39 | regulation of cholesterol esterification (GO:0010872) | 4.83432230 |
| 40 | bile acid and bile salt transport (GO:0015721) | 4.70866503 |
| 41 | macromolecular complex remodeling (GO:0034367) | 4.70572711 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.70572711 |
| 43 | protein-lipid complex remodeling (GO:0034368) | 4.70572711 |
| 44 | phospholipid efflux (GO:0033700) | 4.62526302 |
| 45 | homocysteine metabolic process (GO:0050667) | 4.61291303 |
| 46 | regulation of triglyceride catabolic process (GO:0010896) | 4.60826242 |
| 47 | indolalkylamine metabolic process (GO:0006586) | 4.59516200 |
| 48 | cellular ketone body metabolic process (GO:0046950) | 4.59140719 |
| 49 | acylglycerol homeostasis (GO:0055090) | 4.53565091 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.53565091 |
| 51 | coenzyme catabolic process (GO:0009109) | 4.50704310 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 4.50418093 |
| 53 | cellular biogenic amine catabolic process (GO:0042402) | 4.48958004 |
| 54 | amine catabolic process (GO:0009310) | 4.48958004 |
| 55 | negative regulation of sterol transport (GO:0032372) | 4.35366246 |
| 56 | negative regulation of cholesterol transport (GO:0032375) | 4.35366246 |
| 57 | imidazole-containing compound metabolic process (GO:0052803) | 4.33719225 |
| 58 | amino-acid betaine metabolic process (GO:0006577) | 4.31843056 |
| 59 | cholesterol efflux (GO:0033344) | 4.25500415 |
| 60 | negative regulation of hemostasis (GO:1900047) | 4.20053517 |
| 61 | negative regulation of blood coagulation (GO:0030195) | 4.20053517 |
| 62 | lysine catabolic process (GO:0006554) | 4.17224907 |
| 63 | lysine metabolic process (GO:0006553) | 4.17224907 |
| 64 | benzene-containing compound metabolic process (GO:0042537) | 4.16278928 |
| 65 | cellular glucuronidation (GO:0052695) | 4.14679857 |
| 66 | cellular amino acid catabolic process (GO:0009063) | 4.13800651 |
| 67 | protein-lipid complex subunit organization (GO:0071825) | 4.13097354 |
| 68 | plasma lipoprotein particle clearance (GO:0034381) | 4.10575629 |
| 69 | glutamate metabolic process (GO:0006536) | 4.05262156 |
| 70 | regulation of apoptotic cell clearance (GO:2000425) | 4.03271519 |
| 71 | arginine metabolic process (GO:0006525) | 4.02410121 |
| 72 | cellular modified amino acid catabolic process (GO:0042219) | 4.02003971 |
| 73 | low-density lipoprotein particle remodeling (GO:0034374) | 3.98826975 |
| 74 | complement activation, classical pathway (GO:0006958) | 3.97980862 |
| 75 | fibrinolysis (GO:0042730) | 3.95881233 |
| 76 | ketone body metabolic process (GO:1902224) | 3.95058488 |
| 77 | drug catabolic process (GO:0042737) | 3.91043701 |
| 78 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.90151409 |
| 79 | negative regulation of coagulation (GO:0050819) | 3.89622400 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 3.86582180 |
| 81 | negative regulation of lipase activity (GO:0060192) | 3.85791810 |
| 82 | complement activation (GO:0006956) | 3.85523559 |
| 83 | glycine metabolic process (GO:0006544) | 3.82283119 |
| 84 | blood coagulation, intrinsic pathway (GO:0007597) | 3.80873189 |
| 85 | protein activation cascade (GO:0072376) | 3.79505097 |
| 86 | ethanol oxidation (GO:0006069) | 3.78980645 |
| 87 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.78881500 |
| 88 | acute-phase response (GO:0006953) | 3.76583002 |
| 89 | negative regulation of wound healing (GO:0061045) | 3.75553073 |
| 90 | aldehyde catabolic process (GO:0046185) | 3.75156777 |
| 91 | phospholipid homeostasis (GO:0055091) | 3.73811107 |
| 92 | uronic acid metabolic process (GO:0006063) | 3.72760630 |
| 93 | glucuronate metabolic process (GO:0019585) | 3.72760630 |
| 94 | NAD biosynthetic process (GO:0009435) | 3.71289841 |
| 95 | cofactor catabolic process (GO:0051187) | 3.71134944 |
| 96 | regulation of bile acid biosynthetic process (GO:0070857) | 3.70869995 |
| 97 | positive regulation of blood coagulation (GO:0030194) | 3.70796833 |
| 98 | positive regulation of hemostasis (GO:1900048) | 3.70796833 |
| 99 | serine family amino acid metabolic process (GO:0009069) | 3.68777284 |
| 100 | cytolysis (GO:0019835) | 3.67479207 |
| 101 | carboxylic acid catabolic process (GO:0046395) | 3.61424820 |
| 102 | organic acid catabolic process (GO:0016054) | 3.61424820 |
| 103 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.60650026 |
| 104 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.59587789 |
| 105 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.59587789 |
| 106 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.56658879 |
| 107 | cholesterol homeostasis (GO:0042632) | 3.55104571 |
| 108 | plasma lipoprotein particle organization (GO:0071827) | 3.54285724 |
| 109 | positive regulation of coagulation (GO:0050820) | 3.53118821 |
| 110 | positive regulation of lipid catabolic process (GO:0050996) | 3.51567872 |
| 111 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.49557352 |
| 112 | sterol homeostasis (GO:0055092) | 3.49015554 |
| 113 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.48754261 |
| 114 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.48754261 |
| 115 | exogenous drug catabolic process (GO:0042738) | 3.48500167 |
| 116 | negative regulation of protein activation cascade (GO:2000258) | 3.48113826 |
| 117 | drug metabolic process (GO:0017144) | 3.48005172 |
| 118 | sterol transport (GO:0015918) | 3.47590509 |
| 119 | cholesterol transport (GO:0030301) | 3.47590509 |
| 120 | oxidative demethylation (GO:0070989) | 3.44773684 |
| 121 | protein-lipid complex assembly (GO:0065005) | 3.43033541 |
| 122 | peptidyl-glutamic acid modification (GO:0018200) | 3.42221754 |
| 123 | lipoprotein metabolic process (GO:0042157) | 3.33730958 |
| 124 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.30838371 |
| 125 | regulation of cholesterol homeostasis (GO:2000188) | 3.23882360 |
| 126 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.15125293 |
| 127 | intestinal absorption (GO:0050892) | 3.13586462 |
| 128 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.11414042 |
| 129 | proline metabolic process (GO:0006560) | 3.09764265 |
| 130 | serine family amino acid biosynthetic process (GO:0009070) | 3.09667315 |
| 131 | regulation of humoral immune response (GO:0002920) | 3.09526060 |
| 132 | ethanol metabolic process (GO:0006067) | 3.09005387 |
| 133 | heme transport (GO:0015886) | 3.04484250 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.37199673 |
| 2 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.27715912 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.18551217 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.78073618 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.03391572 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.28778854 |
| 7 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.96165639 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.79598055 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.65479568 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.36790050 |
| 11 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.30460776 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.14967113 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.13490328 |
| 14 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.09767229 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4255476 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.82778988 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.82033451 |
| 18 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.75605116 |
| 19 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.63755500 |
| 20 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.58560027 |
| 21 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.56833884 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.54553542 |
| 23 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.45940009 |
| 24 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.45255315 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.41515558 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.40120772 |
| 27 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.39019419 |
| 28 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.39019419 |
| 29 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.39019419 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32781801 |
| 31 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.30436088 |
| 32 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.23907805 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.22647017 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21754429 |
| 35 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.16615033 |
| 36 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.14171878 |
| 37 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.13840632 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12421256 |
| 39 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11394320 |
| 40 | VDR_22108803_ChIP-Seq_LS180_Human | 1.11217680 |
| 41 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.10635774 |
| 42 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.10228932 |
| 43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.05214237 |
| 44 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.03931133 |
| 45 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03572491 |
| 46 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.01739705 |
| 47 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.00675271 |
| 48 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00158900 |
| 49 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98559961 |
| 50 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.98000395 |
| 51 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.98000395 |
| 52 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97756390 |
| 53 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97705488 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.97229674 |
| 55 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.97225205 |
| 56 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96715662 |
| 57 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95613661 |
| 58 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.95442535 |
| 59 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95421107 |
| 60 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93398481 |
| 61 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.91889162 |
| 62 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.87281156 |
| 63 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.87171623 |
| 64 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.86599213 |
| 65 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83471695 |
| 66 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.83430252 |
| 67 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83010047 |
| 68 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.82367566 |
| 69 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82335066 |
| 70 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.81590325 |
| 71 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.81394475 |
| 72 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.80345108 |
| 73 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.79886298 |
| 74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.78209977 |
| 75 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.77624891 |
| 76 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.77106394 |
| 77 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.77024673 |
| 78 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75215581 |
| 79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75215581 |
| 80 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.74971150 |
| 81 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.74666811 |
| 82 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.74633973 |
| 83 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.74529763 |
| 84 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.74428567 |
| 85 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.74331096 |
| 86 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.74226229 |
| 87 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73170827 |
| 88 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.73015170 |
| 89 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.72810104 |
| 90 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.72175957 |
| 91 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.71674487 |
| 92 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.71538798 |
| 93 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.71009400 |
| 94 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71009400 |
| 95 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.70761709 |
| 96 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.69824494 |
| 97 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.69149780 |
| 98 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.68181559 |
| 99 | P300_19829295_ChIP-Seq_ESCs_Human | 0.68068148 |
| 100 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.67974286 |
| 101 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67930643 |
| 102 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67892649 |
| 103 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.67788594 |
| 104 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.67232678 |
| 105 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.67086385 |
| 106 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.66939790 |
| 107 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.66032971 |
| 108 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.65992463 |
| 109 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.65952187 |
| 110 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.65871209 |
| 111 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.64810420 |
| 112 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.63984380 |
| 113 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.63720857 |
| 114 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.62899982 |
| 115 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.61961715 |
| 116 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.61855553 |
| 117 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.61661645 |
| 118 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60726687 |
| 119 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.59656540 |
| 120 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.58861331 |
| 121 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.58301607 |
| 122 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.57866102 |
| 123 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.57566187 |
| 124 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.57283533 |
| 125 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.56784605 |
| 126 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.56713959 |
| 127 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.56692373 |
| 128 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.56490156 |
| 129 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.56228879 |
| 130 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.56002229 |
| 131 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.55543596 |
| 132 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.55219471 |
| 133 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.53959805 |
| 134 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.53958923 |
| 135 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.53894225 |
| 136 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.53623645 |
| 137 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53564053 |
| 138 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.53532374 |
| 139 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.53517351 |
| 140 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.53406101 |
| 141 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.53070766 |
| 142 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.52763944 |
| 143 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.52694738 |
| 144 | KDM2B_26808549_Chip-Seq_REH_Human | 0.52021345 |
| 145 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.51940750 |
| 146 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.51597629 |
| 147 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.51349809 |
| 148 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.51080284 |
| 149 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.50643634 |
| 150 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50167373 |
| 151 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.50024784 |
| 152 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.49369052 |
| 153 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.49353111 |
| 154 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.49064174 |
| 155 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.48954381 |
| 156 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.48512423 |
| 157 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.48213904 |
| 158 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.48143094 |
| 159 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.48023870 |
| 160 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.47884223 |
| 161 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.46792575 |
| 162 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46241432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.20418407 |
| 2 | MP0005360_urolithiasis | 7.42093008 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.61605343 |
| 4 | MP0005365_abnormal_bile_salt | 6.16874319 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.01641736 |
| 6 | MP0003252_abnormal_bile_duct | 4.09493748 |
| 7 | MP0003122_maternal_imprinting | 3.98218696 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.54979956 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.51789757 |
| 10 | MP0009840_abnormal_foam_cell | 3.07748684 |
| 11 | MP0005083_abnormal_biliary_tract | 2.87386363 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.65843154 |
| 13 | MP0005332_abnormal_amino_acid | 2.62186233 |
| 14 | MP0003195_calcinosis | 2.57470524 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.41437718 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.23936061 |
| 17 | MP0004133_heterotaxia | 2.15866341 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.05825055 |
| 19 | MP0003868_abnormal_feces_composition | 2.05560595 |
| 20 | MP0000609_abnormal_liver_physiology | 2.04395329 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.87443038 |
| 22 | MP0009697_abnormal_copulation | 1.81484435 |
| 23 | MP0005058_abnormal_lysosome_morphology | 1.75862585 |
| 24 | MP0002089_abnormal_postnatal_growth/wei | 1.69527939 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.67112952 |
| 26 | MP0001764_abnormal_homeostasis | 1.62721950 |
| 27 | MP0005257_abnormal_intraocular_pressure | 1.58763838 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.51147405 |
| 29 | MP0003283_abnormal_digestive_organ | 1.48760759 |
| 30 | MP0006292_abnormal_olfactory_placode | 1.48550598 |
| 31 | MP0003121_genomic_imprinting | 1.39291458 |
| 32 | MP0005451_abnormal_body_composition | 1.31982302 |
| 33 | MP0005647_abnormal_sex_gland | 1.31858865 |
| 34 | MP0001529_abnormal_vocalization | 1.31811806 |
| 35 | MP0005167_abnormal_blood-brain_barrier | 1.28475005 |
| 36 | MP0003011_delayed_dark_adaptation | 1.27527519 |
| 37 | MP0005499_abnormal_olfactory_system | 1.24314806 |
| 38 | MP0005394_taste/olfaction_phenotype | 1.24314806 |
| 39 | MP0002822_catalepsy | 1.22849460 |
| 40 | MP0002938_white_spotting | 1.22801987 |
| 41 | MP0001915_intracranial_hemorrhage | 1.19740168 |
| 42 | MP0003890_abnormal_embryonic-extraembry | 1.12834568 |
| 43 | MP0002254_reproductive_system_inflammat | 1.11833745 |
| 44 | MP0009764_decreased_sensitivity_to | 1.09795557 |
| 45 | MP0006054_spinal_hemorrhage | 1.09164318 |
| 46 | MP0009643_abnormal_urine_homeostasis | 1.09158664 |
| 47 | MP0003656_abnormal_erythrocyte_physiolo | 1.06108632 |
| 48 | MP0003136_yellow_coat_color | 1.04266797 |
| 49 | MP0000598_abnormal_liver_morphology | 1.02807374 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.01138955 |
| 51 | MP0003186_abnormal_redox_activity | 0.99043746 |
| 52 | MP0000604_amyloidosis | 0.98052435 |
| 53 | MP0003123_paternal_imprinting | 0.96284377 |
| 54 | MP0002233_abnormal_nose_morphology | 0.95140849 |
| 55 | MP0003119_abnormal_digestive_system | 0.94438737 |
| 56 | MP0001293_anophthalmia | 0.93775914 |
| 57 | MP0002697_abnormal_eye_size | 0.91642975 |
| 58 | MP0002909_abnormal_adrenal_gland | 0.91106794 |
| 59 | MP0009763_increased_sensitivity_to | 0.88667632 |
| 60 | MP0009642_abnormal_blood_homeostasis | 0.88574381 |
| 61 | MP0002282_abnormal_trachea_morphology | 0.87976324 |
| 62 | MP0005535_abnormal_body_temperature | 0.87916112 |
| 63 | MP0005084_abnormal_gallbladder_morpholo | 0.86189092 |
| 64 | MP0002653_abnormal_ependyma_morphology | 0.84993782 |
| 65 | MP0008469_abnormal_protein_level | 0.84912376 |
| 66 | MP0010368_abnormal_lymphatic_system | 0.84233882 |
| 67 | MP0005636_abnormal_mineral_homeostasis | 0.84215041 |
| 68 | MP0002928_abnormal_bile_duct | 0.82821266 |
| 69 | MP0004272_abnormal_basement_membrane | 0.82107862 |
| 70 | MP0005670_abnormal_white_adipose | 0.81177363 |
| 71 | MP0003385_abnormal_body_wall | 0.80985594 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 0.79942055 |
| 73 | MP0003690_abnormal_glial_cell | 0.78286233 |
| 74 | MP0005334_abnormal_fat_pad | 0.76766763 |
| 75 | MP0006276_abnormal_autonomic_nervous | 0.76441423 |
| 76 | MP0005379_endocrine/exocrine_gland_phen | 0.74062334 |
| 77 | MP0003567_abnormal_fetal_cardiomyocyte | 0.74038069 |
| 78 | MP0005376_homeostasis/metabolism_phenot | 0.72363129 |
| 79 | MP0002092_abnormal_eye_morphology | 0.72252217 |
| 80 | MP0009053_abnormal_anal_canal | 0.72239005 |
| 81 | MP0009765_abnormal_xenobiotic_induced | 0.71291678 |
| 82 | MP0008789_abnormal_olfactory_epithelium | 0.71278301 |
| 83 | MP0004142_abnormal_muscle_tone | 0.68161063 |
| 84 | MP0005551_abnormal_eye_electrophysiolog | 0.67772085 |
| 85 | MP0000639_abnormal_adrenal_gland | 0.66634971 |
| 86 | MP0005448_abnormal_energy_balance | 0.65974711 |
| 87 | MP0000778_abnormal_nervous_system | 0.65906478 |
| 88 | MP0005220_abnormal_exocrine_pancreas | 0.65839333 |
| 89 | MP0002249_abnormal_larynx_morphology | 0.65414856 |
| 90 | MP0003303_peritoneal_inflammation | 0.65157677 |
| 91 | MP0005187_abnormal_penis_morphology | 0.64906381 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 0.64594146 |
| 93 | MP0001756_abnormal_urination | 0.64375978 |
| 94 | MP0008874_decreased_physiological_sensi | 0.64238494 |
| 95 | MP0006082_CNS_inflammation | 0.64040561 |
| 96 | MP0003942_abnormal_urinary_system | 0.63984355 |
| 97 | MP0005464_abnormal_platelet_physiology | 0.62952477 |
| 98 | MP0010030_abnormal_orbit_morphology | 0.61994657 |
| 99 | MP0005377_hearing/vestibular/ear_phenot | 0.61825331 |
| 100 | MP0003878_abnormal_ear_physiology | 0.61825331 |
| 101 | MP0008872_abnormal_physiological_respon | 0.61056442 |
| 102 | MP0005408_hypopigmentation | 0.60234773 |
| 103 | MP0004883_abnormal_blood_vessel | 0.59497223 |
| 104 | MP0000049_abnormal_middle_ear | 0.59371158 |
| 105 | MP0003632_abnormal_nervous_system | 0.59193098 |
| 106 | MP0002971_abnormal_brown_adipose | 0.58921639 |
| 107 | MP0000538_abnormal_urinary_bladder | 0.58397688 |
| 108 | MP0004130_abnormal_muscle_cell | 0.57540949 |
| 109 | MP0005195_abnormal_posterior_eye | 0.56519627 |
| 110 | MP0002557_abnormal_social/conspecific_i | 0.55304499 |
| 111 | MP0003937_abnormal_limbs/digits/tail_de | 0.55245620 |
| 112 | MP0003938_abnormal_ear_development | 0.54788580 |
| 113 | MP0000566_synostosis | 0.53619439 |
| 114 | MP0003329_amyloid_beta_deposits | 0.53107509 |
| 115 | MP0003953_abnormal_hormone_level | 0.52852356 |
| 116 | MP0003638_abnormal_response/metabolism_ | 0.52595179 |
| 117 | MP0003315_abnormal_perineum_morphology | 0.51417656 |
| 118 | MP0001286_abnormal_eye_development | 0.51384547 |
| 119 | MP0002184_abnormal_innervation | 0.51331184 |
| 120 | MP0003075_altered_response_to | 0.51013456 |
| 121 | MP0002111_abnormal_tail_morphology | 0.50865601 |
| 122 | MP0005646_abnormal_pituitary_gland | 0.49500937 |
| 123 | MP0000371_diluted_coat_color | 0.49474402 |
| 124 | MP0002090_abnormal_vision | 0.48993953 |
| 125 | MP0005166_decreased_susceptibility_to | 0.48729730 |
| 126 | MP0003724_increased_susceptibility_to | 0.48325167 |
| 127 | MP0006036_abnormal_mitochondrial_physio | 0.46021372 |
| 128 | MP0005391_vision/eye_phenotype | 0.45964576 |
| 129 | MP0005266_abnormal_metabolism | 0.45789998 |
| 130 | MP0000955_abnormal_spinal_cord | 0.45779488 |
| 131 | MP0000026_abnormal_inner_ear | 0.45643900 |
| 132 | MP0003705_abnormal_hypodermis_morpholog | 0.42249810 |
| 133 | MP0009672_abnormal_birth_weight | 0.39301836 |
| 134 | MP0002136_abnormal_kidney_physiology | 0.39084207 |
| 135 | MP0005395_other_phenotype | 0.38987789 |
| 136 | MP0000230_abnormal_systemic_arterial | 0.38378802 |
| 137 | MP0006035_abnormal_mitochondrial_morpho | 0.37448220 |
| 138 | MP0002132_abnormal_respiratory_system | 0.37227105 |
| 139 | MP0008873_increased_physiological_sensi | 0.37043604 |
| 140 | MP0004381_abnormal_hair_follicle | 0.36814672 |
| 141 | MP0003718_maternal_effect | 0.36265475 |
| 142 | MP0001661_extended_life_span | 0.34840524 |
| 143 | MP0001984_abnormal_olfaction | 0.34691296 |
| 144 | MP0002069_abnormal_eating/drinking_beha | 0.34654268 |
| 145 | MP0000579_abnormal_nail_morphology | 0.32461056 |
| 146 | MP0005248_abnormal_Harderian_gland | 0.32087107 |
| 147 | MP0009115_abnormal_fat_cell | 0.31018031 |
| 148 | MP0001324_abnormal_eye_pigmentation | 0.30790791 |
| 149 | MP0001502_abnormal_circadian_rhythm | 0.30418700 |
| 150 | MP0000249_abnormal_blood_vessel | 0.30020736 |
| 151 | MP0005595_abnormal_vascular_smooth | 0.29483918 |
| 152 | MP0003633_abnormal_nervous_system | 0.29073677 |
| 153 | MP0005164_abnormal_response_to | 0.28432314 |
| 154 | MP0005197_abnormal_uvea_morphology | 0.26896031 |
| 155 | MP0003172_abnormal_lysosome_physiology | 0.25610787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.22295002 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.17176626 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.06556530 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.67813641 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.45466196 |
| 6 | Complement deficiency (HP:0004431) | 6.35588428 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.12357470 |
| 8 | Xanthomatosis (HP:0000991) | 5.93904817 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.34993124 |
| 10 | Joint hemorrhage (HP:0005261) | 4.98676332 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.58196996 |
| 12 | Abnormality of complement system (HP:0005339) | 4.54645959 |
| 13 | Epidermoid cyst (HP:0200040) | 4.40684834 |
| 14 | Hyperammonemia (HP:0001987) | 4.35764338 |
| 15 | Hyperglycinemia (HP:0002154) | 4.30481512 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 4.26044881 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.22383430 |
| 18 | Conjugated hyperbilirubinemia (HP:0002908) | 4.21925982 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.18972577 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.15539955 |
| 21 | Ketosis (HP:0001946) | 4.10869726 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.09834946 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.05540362 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 4.03587810 |
| 25 | Fat malabsorption (HP:0002630) | 4.00571448 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.93814514 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.82382148 |
| 28 | Glomerulonephritis (HP:0000099) | 3.69221026 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 3.62642204 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.62642204 |
| 31 | Hyperglycinuria (HP:0003108) | 3.61171399 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.55976432 |
| 33 | Hypoglycemic coma (HP:0001325) | 3.38819966 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.36799577 |
| 35 | Delayed CNS myelination (HP:0002188) | 3.17804928 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.16838863 |
| 37 | Hyperbilirubinemia (HP:0002904) | 3.15111876 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.09362059 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 2.97824970 |
| 40 | Steatorrhea (HP:0002570) | 2.97412255 |
| 41 | Hypochromic microcytic anemia (HP:0004840) | 2.95183922 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 2.94178801 |
| 43 | Spontaneous abortion (HP:0005268) | 2.88744304 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 2.85977951 |
| 45 | Ketoacidosis (HP:0001993) | 2.82188011 |
| 46 | Myocardial infarction (HP:0001658) | 2.74771101 |
| 47 | Metabolic acidosis (HP:0001942) | 2.67842751 |
| 48 | Vascular calcification (HP:0004934) | 2.62870648 |
| 49 | Skin nodule (HP:0200036) | 2.61473550 |
| 50 | Bifid scrotum (HP:0000048) | 2.57685813 |
| 51 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.55391484 |
| 52 | Amyloidosis (HP:0011034) | 2.52714907 |
| 53 | Abnormality of purine metabolism (HP:0004352) | 2.50077128 |
| 54 | Hypoglycemic seizures (HP:0002173) | 2.49625274 |
| 55 | Mitral stenosis (HP:0001718) | 2.45875515 |
| 56 | Enlarged kidneys (HP:0000105) | 2.39344611 |
| 57 | Lethargy (HP:0001254) | 2.39225129 |
| 58 | Neonatal onset (HP:0003623) | 2.36650622 |
| 59 | Broad alveolar ridges (HP:0000187) | 2.32735969 |
| 60 | Irritability (HP:0000737) | 2.31945968 |
| 61 | Acanthocytosis (HP:0001927) | 2.31190785 |
| 62 | Vacuolated lymphocytes (HP:0001922) | 2.29441904 |
| 63 | Sensorimotor neuropathy (HP:0007141) | 2.28350172 |
| 64 | Retinal atrophy (HP:0001105) | 2.28328806 |
| 65 | Cardiovascular calcification (HP:0011915) | 2.26833338 |
| 66 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.26472478 |
| 67 | Dicarboxylic aciduria (HP:0003215) | 2.26472478 |
| 68 | Gout (HP:0001997) | 2.25131038 |
| 69 | Nephritis (HP:0000123) | 2.23795634 |
| 70 | Purpura (HP:0000979) | 2.23019210 |
| 71 | Cholecystitis (HP:0001082) | 2.22709692 |
| 72 | Abnormal gallbladder physiology (HP:0012438) | 2.22709692 |
| 73 | Abnormal gallbladder morphology (HP:0012437) | 2.20370640 |
| 74 | Abnormality of the lumbar spine (HP:0100712) | 2.19582864 |
| 75 | Menorrhagia (HP:0000132) | 2.18297102 |
| 76 | Cerebral edema (HP:0002181) | 2.17170870 |
| 77 | Gingival bleeding (HP:0000225) | 2.15690320 |
| 78 | Arthropathy (HP:0003040) | 2.12578949 |
| 79 | Opisthotonus (HP:0002179) | 2.11563903 |
| 80 | Increased serum pyruvate (HP:0003542) | 2.11190946 |
| 81 | Vaginal fistula (HP:0004320) | 2.10783783 |
| 82 | Cholelithiasis (HP:0001081) | 2.10205003 |
| 83 | Glycosuria (HP:0003076) | 2.10152590 |
| 84 | Abnormality of urine glucose concentration (HP:0011016) | 2.10152590 |
| 85 | Pancreatitis (HP:0001733) | 2.02830595 |
| 86 | Status epilepticus (HP:0002133) | 2.02486107 |
| 87 | Hypophosphatemic rickets (HP:0004912) | 2.01595265 |
| 88 | Malnutrition (HP:0004395) | 2.01575197 |
| 89 | Rickets (HP:0002748) | 1.99062920 |
| 90 | Brushfield spots (HP:0001088) | 1.98068921 |
| 91 | Thrombophlebitis (HP:0004418) | 1.97903511 |
| 92 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.97475275 |
| 93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.97475275 |
| 94 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.97475275 |
| 95 | Abnormality of proline metabolism (HP:0010907) | 1.97244741 |
| 96 | Hydroxyprolinuria (HP:0003080) | 1.97244741 |
| 97 | Abnormality of the vitreous humor (HP:0004327) | 1.95218891 |
| 98 | Vomiting (HP:0002013) | 1.94493267 |
| 99 | Spastic diplegia (HP:0001264) | 1.93819371 |
| 100 | Osteomalacia (HP:0002749) | 1.93569083 |
| 101 | Esophageal varix (HP:0002040) | 1.92335044 |
| 102 | Hepatoblastoma (HP:0002884) | 1.92039489 |
| 103 | Hemorrhage of the eye (HP:0011885) | 1.90879501 |
| 104 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.88782974 |
| 105 | Mucopolysacchariduria (HP:0008155) | 1.88782974 |
| 106 | Alkalosis (HP:0001948) | 1.87938183 |
| 107 | Abnormality of the gallbladder (HP:0005264) | 1.87715925 |
| 108 | Renal cortical cysts (HP:0000803) | 1.86988710 |
| 109 | Abnormality of glycolysis (HP:0004366) | 1.85576388 |
| 110 | Late onset (HP:0003584) | 1.85296825 |
| 111 | Abnormal tarsal ossification (HP:0008369) | 1.82677947 |
| 112 | Generalized aminoaciduria (HP:0002909) | 1.81788559 |
| 113 | Hyperphosphaturia (HP:0003109) | 1.80818060 |
| 114 | Fair hair (HP:0002286) | 1.80209811 |
| 115 | Neonatal hypoglycemia (HP:0001998) | 1.79965315 |
| 116 | Upper motor neuron abnormality (HP:0002127) | 1.79124871 |
| 117 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78461645 |
| 118 | Bile duct proliferation (HP:0001408) | 1.78181395 |
| 119 | Abnormal biliary tract physiology (HP:0012439) | 1.78181395 |
| 120 | Poikilocytosis (HP:0004447) | 1.75278368 |
| 121 | Abnormality of vitamin metabolism (HP:0100508) | 1.72680745 |
| 122 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.72257418 |
| 123 | Small epiphyses (HP:0010585) | 1.66935132 |
| 124 | Neurofibrillary tangles (HP:0002185) | 1.64992246 |
| 125 | Vitreoretinal degeneration (HP:0000655) | 1.60654648 |
| 126 | Recurrent corneal erosions (HP:0000495) | 1.58503701 |
| 127 | Lissencephaly (HP:0001339) | 1.58247504 |
| 128 | Myelomeningocele (HP:0002475) | 1.57954197 |
| 129 | Trigonocephaly (HP:0000243) | 1.55462637 |
| 130 | Abnormality of carpal bone ossification (HP:0006257) | 1.54451288 |
| 131 | Epiphyseal dysplasia (HP:0002656) | 1.53278151 |
| 132 | Abnormal urine phosphate concentration (HP:0012599) | 1.53103718 |
| 133 | Pendular nystagmus (HP:0012043) | 1.52510367 |
| 134 | Mesangial abnormality (HP:0001966) | 1.52247714 |
| 135 | Bifid tongue (HP:0010297) | 1.46956371 |
| 136 | Humeroradial synostosis (HP:0003041) | 1.45261909 |
| 137 | Synostosis involving the elbow (HP:0003938) | 1.45261909 |
| 138 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.44763884 |
| 139 | Abnormality of the nasal septum (HP:0000419) | 1.44544119 |
| 140 | Potter facies (HP:0002009) | 1.44124487 |
| 141 | Facial shape deformation (HP:0011334) | 1.44124487 |
| 142 | Irregular epiphyses (HP:0010582) | 1.43403072 |
| 143 | Hypothermia (HP:0002045) | 1.42665274 |
| 144 | Prominent supraorbital ridges (HP:0000336) | 1.41868185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.21068376 |
| 2 | SIK1 | 3.87162180 |
| 3 | FGFR4 | 3.59837207 |
| 4 | MAP3K9 | 3.50722489 |
| 5 | WNK4 | 3.34592929 |
| 6 | INSRR | 3.11065170 |
| 7 | ERN1 | 3.01654834 |
| 8 | MAP2K4 | 2.84834149 |
| 9 | MAPK15 | 2.80981214 |
| 10 | TGFBR2 | 2.74538975 |
| 11 | TNIK | 2.46678267 |
| 12 | ERBB4 | 2.45271149 |
| 13 | DDR2 | 2.40439607 |
| 14 | TYRO3 | 2.32772615 |
| 15 | TAOK3 | 2.17229527 |
| 16 | MAP4K2 | 2.15200228 |
| 17 | DAPK2 | 2.07900741 |
| 18 | MATK | 2.00327460 |
| 19 | GRK7 | 1.81520866 |
| 20 | BCR | 1.80923065 |
| 21 | MARK1 | 1.77097618 |
| 22 | SIK3 | 1.74129554 |
| 23 | FGFR3 | 1.69047854 |
| 24 | TRIM28 | 1.65017091 |
| 25 | PIK3CG | 1.56291896 |
| 26 | TYK2 | 1.53583660 |
| 27 | MAPK11 | 1.40061815 |
| 28 | MST1R | 1.38629241 |
| 29 | SGK2 | 1.33694222 |
| 30 | MAP3K4 | 1.32477379 |
| 31 | MAP2K7 | 1.32423551 |
| 32 | FRK | 1.32290526 |
| 33 | MAPK12 | 1.30417218 |
| 34 | PIM2 | 1.29647604 |
| 35 | SIK2 | 1.26572750 |
| 36 | FGFR1 | 1.25108887 |
| 37 | CASK | 1.22150793 |
| 38 | MAPK4 | 1.18580125 |
| 39 | FGFR2 | 1.17573068 |
| 40 | WNK3 | 1.14498342 |
| 41 | CSF1R | 1.14266363 |
| 42 | RIPK1 | 1.14097616 |
| 43 | MAP3K11 | 1.12774805 |
| 44 | FGR | 1.11520563 |
| 45 | PRKCZ | 1.10634706 |
| 46 | CAMK1D | 1.06895821 |
| 47 | CHUK | 1.05828061 |
| 48 | ADRBK2 | 1.05812562 |
| 49 | DYRK3 | 1.04415366 |
| 50 | DYRK1B | 1.03347324 |
| 51 | SGK3 | 1.01246994 |
| 52 | PRKAA2 | 0.99628411 |
| 53 | CDK12 | 0.98681022 |
| 54 | JAK1 | 0.98186670 |
| 55 | ERBB2 | 0.96030161 |
| 56 | JAK2 | 0.94942005 |
| 57 | SGK494 | 0.94938550 |
| 58 | SGK223 | 0.94938550 |
| 59 | STK38L | 0.94004743 |
| 60 | MAP3K14 | 0.93968681 |
| 61 | LATS1 | 0.93510679 |
| 62 | NME2 | 0.92259059 |
| 63 | EPHA4 | 0.91174755 |
| 64 | PINK1 | 0.90076474 |
| 65 | MAP2K6 | 0.88381141 |
| 66 | FLT3 | 0.86764676 |
| 67 | IRAK3 | 0.86397513 |
| 68 | NEK9 | 0.86306643 |
| 69 | ZAK | 0.85869295 |
| 70 | MAP3K6 | 0.84967613 |
| 71 | MAPK7 | 0.83641582 |
| 72 | ABL2 | 0.79807283 |
| 73 | PKN1 | 0.79605973 |
| 74 | PDGFRA | 0.77921198 |
| 75 | CAMK4 | 0.76669144 |
| 76 | CSNK1G2 | 0.75238501 |
| 77 | CAMK1G | 0.73245052 |
| 78 | PRKD3 | 0.72379784 |
| 79 | AKT3 | 0.72367496 |
| 80 | EPHB2 | 0.71758872 |
| 81 | PTK6 | 0.71155633 |
| 82 | MAP3K7 | 0.71112648 |
| 83 | CSNK1G1 | 0.70933361 |
| 84 | ARAF | 0.69446260 |
| 85 | PRKACG | 0.69098122 |
| 86 | PRKAA1 | 0.65662653 |
| 87 | TIE1 | 0.65547974 |
| 88 | TLK1 | 0.64937284 |
| 89 | TBK1 | 0.64471265 |
| 90 | MAP2K3 | 0.64062768 |
| 91 | PKN2 | 0.62535299 |
| 92 | CSNK1G3 | 0.62307888 |
| 93 | GRK5 | 0.61501669 |
| 94 | CSNK1E | 0.60817171 |
| 95 | GSK3A | 0.59423339 |
| 96 | TAF1 | 0.59160946 |
| 97 | CAMK2G | 0.59102407 |
| 98 | PRKCG | 0.58178450 |
| 99 | TAOK2 | 0.58160496 |
| 100 | NTRK2 | 0.58055830 |
| 101 | ACVR1B | 0.56566828 |
| 102 | LATS2 | 0.56317297 |
| 103 | IGF1R | 0.56123777 |
| 104 | CSNK1D | 0.56086960 |
| 105 | IKBKB | 0.55143402 |
| 106 | CDK15 | 0.54997105 |
| 107 | TRIB3 | 0.54650971 |
| 108 | CDK11A | 0.53479012 |
| 109 | CDK18 | 0.53071668 |
| 110 | MAPK13 | 0.52423564 |
| 111 | IRAK2 | 0.51148161 |
| 112 | DYRK2 | 0.51075414 |
| 113 | NEK2 | 0.50567052 |
| 114 | BMPR1B | 0.50065760 |
| 115 | GRK1 | 0.49737735 |
| 116 | ICK | 0.48847185 |
| 117 | MINK1 | 0.47165523 |
| 118 | EPHA3 | 0.46812727 |
| 119 | MAP2K1 | 0.46344745 |
| 120 | MAP2K2 | 0.46287335 |
| 121 | MAP3K5 | 0.46083269 |
| 122 | EIF2AK2 | 0.44533134 |
| 123 | CSNK2A1 | 0.44292815 |
| 124 | PHKG1 | 0.43556247 |
| 125 | PHKG2 | 0.43556247 |
| 126 | MAP3K3 | 0.43194280 |
| 127 | MAP3K12 | 0.41911866 |
| 128 | RPS6KB1 | 0.41864355 |
| 129 | CDK14 | 0.41538776 |
| 130 | RET | 0.40675843 |
| 131 | GRK6 | 0.40491814 |
| 132 | CSNK1A1L | 0.40398192 |
| 133 | RPS6KA2 | 0.38737412 |
| 134 | CDK3 | 0.38219100 |
| 135 | MAPKAPK5 | 0.37855952 |
| 136 | CDC42BPA | 0.37745037 |
| 137 | CDK7 | 0.36128055 |
| 138 | IRAK1 | 0.35838527 |
| 139 | RPS6KA1 | 0.35827511 |
| 140 | MAP3K13 | 0.35137351 |
| 141 | VRK2 | 0.34950462 |
| 142 | CDK5 | 0.33184141 |
| 143 | CSNK1A1 | 0.32678269 |
| 144 | PDPK1 | 0.31934930 |
| 145 | STK39 | 0.31816624 |
| 146 | CDK6 | 0.30006227 |
| 147 | PRKG1 | 0.28579690 |
| 148 | CAMK2A | 0.28060592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.58936450 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.44337338 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.28159247 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.23660870 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.01455432 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.96804750 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.77559196 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.75985973 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.46223432 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38590444 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.36949282 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31740825 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.27019976 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24627080 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.19411148 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.13546947 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.10015813 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.05638350 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96938397 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96658636 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93624897 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.86616103 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.80945360 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76517638 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.75966023 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72456579 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.72271181 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71274885 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.69135183 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67598612 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64565850 |
| 32 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.59575297 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.54018504 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.53997498 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44892145 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.38477244 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33851306 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32970577 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.32570428 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29332075 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.28590009 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.28311754 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.20648452 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19512271 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11118214 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.08179007 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06540165 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.99325454 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92687871 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92637337 |
| 51 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.92603219 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89960828 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88599434 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88006193 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83591263 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.80548993 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80449994 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.78183005 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76977743 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 0.67592052 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60508176 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56215674 |
| 63 | Protein export_Homo sapiens_hsa03060 | 0.54192827 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49843296 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49133809 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43649178 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43419774 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41273666 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35803482 |
| 70 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34487262 |
| 71 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.34434110 |
| 72 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.29073844 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.27178563 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27077935 |
| 75 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.23874465 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20009134 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19414414 |
| 78 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.18688472 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.18134465 |
| 80 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.17490748 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.17466653 |
| 82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17048153 |
| 83 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.15067871 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.14499692 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.14185426 |
| 86 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.12609409 |
| 87 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.12185483 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11627311 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.11007487 |
| 90 | Phototransduction_Homo sapiens_hsa04744 | 0.10638498 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.10426019 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.09950121 |
| 93 | Axon guidance_Homo sapiens_hsa04360 | 0.07815481 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.07094313 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.03594452 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | -0.1820183 |
| 97 | GABAergic synapse_Homo sapiens_hsa04727 | -0.1787586 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | -0.1750134 |
| 99 | Lysosome_Homo sapiens_hsa04142 | -0.1733946 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1695762 |
| 101 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1684911 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1682528 |
| 103 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.1638867 |
| 104 | Cocaine addiction_Homo sapiens_hsa05030 | -0.1625332 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1605402 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1296738 |
| 107 | Pertussis_Homo sapiens_hsa05133 | -0.1253176 |
| 108 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1209412 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0824635 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0640911 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0447940 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0388784 |
| 113 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0140139 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0050410 |

